Kisha M. Harcum, Vice President of Finance at Milestone Scientific Inc., filed a Form 3 initial statement of beneficial ownership with the SEC on November 20, 2026, reporting no securities beneficially owned as of the event date of January 2, 2025.

Key Highlights

  • Reporting person: Kisha M. Harcum, identified in the filing as Vice President of Finance of Milestone Scientific Inc.
  • Event date: The date of event requiring the statement is listed as January 2, 2025.
  • Filing date: The form was signed and filed on November 20, 2026.
  • No securities held: The filing states "No securities are beneficially owned" in both Table I (non-derivative) and Table II (derivative securities).
  • Issuer: Milestone Scientific Inc., trading on NYSE American under the symbol MLSS, according to the filing.

Milestone Scientific Vice President of Finance Reports Zero Initial Holdings

According to the filing, Kisha M. Harcum submitted a Form 3 initial statement of beneficial ownership in connection with becoming an officer of Milestone Scientific Inc. (NYSE American:MLSS). The filing identifies her role as Vice President of Finance and lists her address as c/o Milestone Scientific, Inc., 425 Eagle Rock Avenue, Roseland, New Jersey 07068.

The event date requiring the statement is reported as January 2, 2025. The form was filed by one reporting person and signed by Kisha Harcum on November 20, 2026. Both Table I, covering non-derivative securities, and Table II, covering derivative securities such as puts, calls, warrants, options, and convertible securities, are left blank. The filing includes the explanation: "No securities are beneficially owned."

Form 3 is required under Section 16(a) of the Securities Exchange Act of 1934 and must be filed by officers, directors, and certain beneficial owners upon first becoming subject to Section 16 reporting obligations. The filing does not indicate any subsequent acquisition or disposition of securities by Harcum.

What Was Disclosed

Kisha M. Harcum, Vice President of Finance at Milestone Scientific Inc., filed an initial beneficial ownership statement reporting no direct or indirect holdings in the company's securities, in either non-derivative or derivative form, as of the event date.